PM
ABBV icon

Parametrica Management’s AbbVie ABBV Stock Holding History

Parametrica Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-2,758
Closed -$241K – 157
2020
Q3 		$241K Buy
+2,758
New +$260K 0.46% 67
2018
Q2 		– Sell
-5,137
Closed -$486K – 55
2018
Q1 		$486K Buy
5,137
+2,220
+76% +$244K 0.6% 33
2017
Q4 		$282K Sell
2,917
-6,117
-68% -$576K 0.18% 228
2017
Q3 		$803K Buy
+9,034
New +$688K 0.34% 28

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Parametrica Management's ABBV Position: Q4 2020 in Review

Parametrica Management sold out of AbbVie (ABBV) in Q4 2020, closing a stake of 2,758 shares — an estimated $241K sold.

Parametrica Management first reported a position in ABBV in Q3 2017 and held it in 4 quarters. The position peaked at $803K in Q3 2017. 2,598 funds tracked by Wall St. Rank hold ABBV as of Q4 2020.

  • Parametrica Management reported no remaining AbbVie position as of Q4 2020 after selling out during the quarter.
  • Parametrica Management sold 2,758 AbbVie shares in Q4 2020, an estimated $241K.
  • Parametrica Management first reported a position in AbbVie in Q3 2017 and held it in 4 quarters.
  • Parametrica Management's AbbVie position peaked at $803K in Q3 2017.
  • 2,598 funds tracked by Wall St. Rank held AbbVie as of Q4 2020.

Based on Parametrica Management's 13F filing for Q4 2020, filed 16 Feb 2021.